Table 1 Demographic and relevant clinical data of the study population (RVI group and controls).
Positive cases (RVI) N = 26 | Negative controls N = 23 | P | hRV N = 7 | hAdV N = 6 | hCoV N = 5 | RSV N = 4 | hBoV N = 3 | |
|---|---|---|---|---|---|---|---|---|
GA (week), median (IQR) | 29.6 (27.9–30.9) | 29.1 (26.4–30.1) | 0.138 | 30 (27.6–30.6) | 31.1 (27.3–39.9) | 28.0 (26.8–28.7) | 30.9 (29.7–30.9) | 31 (28.6–31) |
BW(g) median (IQR) | 1249 (1127–1503) | 1100 (940–1460) | 0.224 | 1290 (1065–1584) | 1495 (1196–1575) | 944 (917–1197) | 1275 (1250–1412) | 1150 (930–1150) |
Male, n (%) | 18 (69%) | 16 (70%) | 0.980 | 5 (71%) | 3 (50%) | 3 (60%) | 4 (100%) | 2 (67%) |
BPD, n (%) | 10 (42%) | 10 (44%) | 0.900 | 1 (14%) | 3 (50%) | 4 (80%) | – | 2 (67%) |
Supplementary oxygen (days), median (IQR) | 19.5 (1–45.2) | 20 (3–48) | 0.721 | 3 (1–35) | 31.5 (1.7–74.7) | 39.0 (27.7–72.5) | 2.5 (1.0–22.7) | 1 |
MV (invasive or non-invasive) (days), median (IQR) | 7 (1–21) | 6 (3–16) | 0.548 | 3 (1–27) | 6.5 (1.7–20) | 19.0 (7.5–40.5) | 2.5 (1.0–22.0) | 1 |
Oxygen at discharge n (%) | 2 (7.7%) | 2 (8.7%) | 0.906 | 1 (14%) | 1 (17%) | – | – | – |
Days to reach full enteral nutrition median (IQR) | 7 (5.7–10.5) | 9 (7–15) | 0.382 | 6 (5–12) | 7.5 (5.7–23.2) | 9 (6.5–11) | 7 (6.2–22.0) | 5 (4–5) |
Length of stay (days), median (IQR) | 59 (37–71) | 61 (48–81) | 0.327 | 38 (36–60) | 62.5 (32.5–96.5) | 67 (62.5–83.0) | 49 (39–68) | 41 (36–41) |
